Navigation Links
Yale Scientist Received Medical Science Prize From Keio University

Thomas A. Steitz received the 11th Keio Medical Science Award from Keio University in Tokyo. Mr. Steitz, a Sterling Professor of Molecular Biophysics and Biochemistry// at Yale, received the award in a ceremony and commemorative symposium conducted by the University on November 1 2006.

The award, made to researchers in recognition of their outstanding achievements in the fields of medical or life sciences, is the only prize of its kind awarded by a Japanese University. It included an honorarium of 20 million yen, a certificate of merit in recognition of his outstanding achievement on the structural basis of the large ribosomal subunit function and drug development, and a commemorative symposium.

Mr. Steitz was honored for research he led that in 2000 produced the first X-ray crystallographic imaging of the large ribosomal subunit. From this work, he and his collaborators have gone on to identify the structural basis of antibiotic drug function and resistance associated with this fundamental cellular structure. They have founded Rib-X, a company developing a new family of antibiotics intended to combat bacteria that have become drug-resistant.

“It is surprising how rapidly our basic research on what was then the ‘central dogma’ of biology, was able to move into the realm of health application,” said Steitz. “We had been studying the fundamentals of DNA replication, RNA transcription and reverse transcription, and protein synthesis. The ability to visualize this cellular machine gave us a whole new way to look at how bacteria develop resistance to antibiotics.”

“When antibiotics work they cure the patient,” said Steitz. Many antibiotics work by blocking a ribosome function that stops bacteria from propagating by interfering with their ability to make proteins. The work of Steitz and his Yale colleague Peter B. Moore, Sterling Professor of Chemistry, shed light on the specific molecular interactions involved between antibiotic
'"/>




Page: 1 2

Related medicine news :

1. Scientists plan human cloning clinic in the United States
2. Scientists found ancient Human Germ Killer
3. Scientists locate key hormone involved in appetite control
4. Scientists open the book of life
5. Scientists review SARS
6. Scientists crack dengue fever puzzle
7. Scientists push to lower hidden sodium in food
8. Indian Scientists Make Wide-Ranging Analysis And Annotation Of X Chromosome
9. Scientists have found effective brain regions for deep brain stimulation for Parkinson’s
10. Scientists reveal the secrets of sarcasm
11. Scientists Unveil Mechanism Behind Resistance to Severe Malaria

Post Your Comments:
(Date:12/2/2009)... Still, taking it for macular degeneration is not.... 2 (HealthDay News) -- Women who take low-dose as...r eyes as well. , A new study by Harvard Univer...dest benefit for aspirin in preventing age-related...estroys sharp, central vision. , "The data indi...
(Date:12/2/2009)..., Educational online even...atient estimations. , Den...thcare Systems (FHS Corp) announced today the laun...ansparency and patient estimations for revenue cyc...The inaugural event will occur on Tuesday, Decembe...
(Date:12/2/2009)..., , LONDON, Dec. 2 /PRNewswire-F...d to the development of improved therapies to trea...opean lifestyle disorders therapeutics market is s...o treat such conditions and reduce the risk of co-...cgi-bin/prnh/20081117/FSLOGO ) ,, New analysis ...
(Date:12/2/2009)..., Bringing in the New Yea...better, be better and take better self-care. What ...o maintain the focus toward goals for 2010? It&rs...den of Eve safe skin care is the primary mission. ...in Deep database, a popular consumer guide to safe...
(Date:12/2/2009)..., Nashville dentist Dr. W...dent of the National Dental Association (NDA) at 6...Hotel in Nashville. , Nas...e dentist Dr. Walter R. Owens will be installed as...tion (NDA) at 6 p.m. on December 5 at the Loews Va...
Breaking Medicine News(10 mins):Health News:In Women, Aspirin Might Ward Off Eye Trouble 2Health News:FHS Corp Announces Price Transparency Webinar Series 2Health News:Development of Newer Therapies to Treat Lifestyle Disorders and Reduce the Risk of Co-morbidities is Key to the Expansion of the European Lifestyle Disorders Therapeutics Market, Says Frost & Sullivan 2Health News:Development of Newer Therapies to Treat Lifestyle Disorders and Reduce the Risk of Co-morbidities is Key to the Expansion of the European Lifestyle Disorders Therapeutics Market, Says Frost & Sullivan 3Health News:The New Year's Resolution that Fuels Them All: Self-Care; Garden of Eve Makes Self-Care Through Safe Skin Care # 1 Priority 2Health News:The New Year's Resolution that Fuels Them All: Self-Care; Garden of Eve Makes Self-Care Through Safe Skin Care # 1 Priority 3Health News:The New Year's Resolution that Fuels Them All: Self-Care; Garden of Eve Makes Self-Care Through Safe Skin Care # 1 Priority 4Health News:Meharry Medical College Officer Will Head the National Dental Association 2Health News:Meharry Medical College Officer Will Head the National Dental Association 3
...dion, OTTAWA, Feb. 5 /PRNewswire-FirstCall/ - MDS...nd radiopharmaceuticals, has appointed Dr. Peter,C...-President Innovation.,Dr. Covitz will lead the gl...rs and support growth at MDS Nordion., "This new ...
...kobstad, Finland, has been included in the Strathm...ing contributions and achievements in the,field of...-bin/prnh/20080205/NYTU012 ), About Mrs. Bojan M...ascular and Thoracic Surgery from Helsingfors Nurs...
...p Inc. (NYSE: JEC ) announced today that it recei...sist in managing the Sequoia Hospital Program,in R...r expansion to the,hospital, including a new 104-b...inished by 2012., Officials estimate the value of...
...nc. (NYSE: WPI ), a leading specialty pharmaceuti...cts to initiate shipments of,alendronate sodium in...n,Fosamax(R) loses market exclusivity, which is an...r the treatment of,osteoporosis in postmenopausal ...
...usiness,Process Outsourcing solutions for health p... Officer, has earned a Certificate in Healthcare,C... from the Compliance,Certification Board of the He...rivacy and information security issues., (Logo: ...
... a biopharmaceutical company developing patient-sp...f cancer, announced today that it will,host a conf...Time on,Tuesday, February 19, 2008 to discuss the ... audio webcast of management,s presentation will b...
Other Medicine News:Health News:Dr. Peter Covitz Joins MDS Nordion as Senior Vice-President Innovation 2Health News:Bojan M. Kuure Recognized by Strathmore's Who's Who Worldwide Publication 2Health News:Jacobs Receives Contract from Catholic Healthcare West to Assist Sequoia Hospital Expansion Program 2Health News:Watson to Distribute Alendronate Tablets 2Health News:Adaptis Compliance Officer Earns Advanced Certificate 2Health News:Favrille to Host Conference Call and Live Webcast to Discuss Fourth Quarter and Year End 2007 Financial Results on February 19, 2008 2
(Date:12/2/2009)..., ROCKVILLE, Md., Dec. 2 /PRNewswire-FirstCall/ ...avorable initial results from the first stage of a...afety and immunogenicity of the company,s 2009 H1N...cine. Novavax is conducting this study in collabo...rt registration of the vaccine in Mexico and poten...
(Date:12/2/2009)..., BIRMINGHAM, Ala., Dec. 2 Adu...iagnosed with cancer. For adults 65 and over, the ...e odds of a man developing prostate cancer are one...er are one in nine. Vision loss threatens the ove... of injuries, depression and inability to complete...
(Date:12/2/2009)..., AMSTERDAM, December 2 /PRNewswire-FirstCall...MT), a leader in the field of human gene therapy,...ers Morgan (age 43) has,been appointed Chief Finan...usting, PhD (age 47), Director Process Development...ity for Operations and Project Management, also,ef...
Breaking Medicine Technology:NOVAVAX Reports Positive Clinical Results from Pivotal Study of H1N1 Influenza Vaccine in Mexico 2NOVAVAX Reports Positive Clinical Results from Pivotal Study of H1N1 Influenza Vaccine in Mexico 3NOVAVAX Reports Positive Clinical Results from Pivotal Study of H1N1 Influenza Vaccine in Mexico 4Risk of Vision Loss in Aging Adults is Greater Than Risk of Breast or Prostate Cancer 2AMT Announces Management Changes in Light of Refocused Strategy 2AMT Announces Management Changes in Light of Refocused Strategy 3Dr Michael Merzenich Joins Venerable Short List Honored for Cutting Edge Neuroscientific Research 14429 1Dr Michael Merzenich Joins Venerable Short List Honored for Cutting Edge Neuroscientific Research 14429 2Dr Michael Merzenich Joins Venerable Short List Honored for Cutting Edge Neuroscientific Research 14429 3Frost 26amp 3B Sullivan Identifies Focus on Quality Management and Adoption of a Full service Model as Keys to the Growth of the European CRO Market 5373 1Frost 26amp 3B Sullivan Identifies Focus on Quality Management and Adoption of a Full service Model as Keys to the Growth of the European CRO Market 5373 2Frost 26amp 3B Sullivan Identifies Focus on Quality Management and Adoption of a Full service Model as Keys to the Growth of the European CRO Market 5373 3Frost 26amp 3B Sullivan Identifies Focus on Quality Management and Adoption of a Full service Model as Keys to the Growth of the European CRO Market 5373 4goBalto Introduces Web based Solution to Manage Drug development Collaborations 14425 1goBalto Introduces Web based Solution to Manage Drug development Collaborations 14425 2
...irstCall/ -- Pharmacyclics (Nasdaq: PCYC ) ann...n with an investment by the principals of Pacific ...California and Taizhou, Jiangsu Province, People,s... as an approximately $1.4 million dollar private i...rt Duggan, CEO of Pharmacyclics noted, "We appreci...
... announced the upcoming,presentation of the PROTEC...Atrial Appendage (LAA) Closure Device to the curre...with non-valvular atrial fibrillation. The,result...rial session during,the I2 Summit Scientific Meeti... part of the Annual Meeting of the American Colleg...
Other Medicine Technology:Pharmacyclics, Inc. Announces Closing of a Private Financing With the Principals of Pacific Biopharma Group, Ltd. 2Pharmacyclics, Inc. Announces Closing of a Private Financing With the Principals of Pacific Biopharma Group, Ltd. 3Atritech to Participate in Late-Breaking Clinical Trial Presentation at American College of Cardiology Meeting 2
...ratories is a national reference laboratory and a ... and development. ARUP offers an extensive test me...linical and anatomic pathology. Owned by the Unive...more than half of the nation's university teaching...
...ratories is a national reference laboratory and a ... and development. ARUP offers an extensive test me...linical and anatomic pathology. Owned by the Unive...more than half of the nation's university teaching...
...ratories is a national reference laboratory and a ... and development. ARUP offers an extensive test me...linical and anatomic pathology. Owned by the Unive...more than half of the nation's university teaching...
...ratories is a national reference laboratory and a ... and development. ARUP offers an extensive test me...linical and anatomic pathology. Owned by the Unive...more than half of the nation's university teaching...
Medicine Products: